
Opinion|Videos|March 14, 2025
Evolving Paradigms: The Role of Systemic Immunotherapy in NPC Treatment
Author(s)Shravan Kandula, MD
An expert discusses emerging developments in the use of systemic immunotherapy for recurrent/metastatic nasopharyngeal carcinoma (NPC) from the perspective of a radiation oncologist, highlighting how findings from Liu et al (Lancet, 2024) inform the evolving treatment landscape.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- With emerging developments in the use of systemic immunotherapy for recurrent/metastatic NPC, what insights can you share from the perspective of a radiation oncologist?
- How do findings from inform the treatment landscape?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Blinatumomab Plus Chemo Show Improved Survival in Infants with KMT2A-r ALL
2
NCCN Updates Breast Cancer Guidelines: Sacituzumab Govitecan for 1L TNBC
3
Bria-IMT Shows Extended Survival in Advanced Metastatic Breast Cancer
4
Evaluating the Molecular Landscape in Endometrial Cancer to Optimize Treatment
5


















